Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 11 studies | 67% ± 24% | |
| GABAergic neuron | 8 studies | 53% ± 26% | |
| retinal ganglion cell | 5 studies | 74% ± 21% | |
| pericyte | 5 studies | 22% ± 6% | |
| interneuron | 4 studies | 54% ± 19% | |
| neuron | 3 studies | 51% ± 25% | |
| endothelial cell | 3 studies | 36% ± 22% | |
| GABAergic interneuron | 3 studies | 39% ± 11% | |
| basal cell | 3 studies | 36% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 12 studies | 41% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 91% | 23452.01 | 2412 / 2642 | 75% | 82.63 | 528 / 705 |
| adrenal gland | 73% | 1234.08 | 189 / 258 | 55% | 18.10 | 127 / 230 |
| esophagus | 39% | 1300.33 | 558 / 1445 | 73% | 39.81 | 133 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 39.11 | 43 / 45 |
| liver | 23% | 221.53 | 52 / 226 | 66% | 12.59 | 268 / 406 |
| intestine | 0% | 3.82 | 3 / 966 | 81% | 24.57 | 429 / 527 |
| heart | 61% | 902.67 | 526 / 861 | 0% | 0 | 0 / 0 |
| stomach | 0% | 0 | 0 / 359 | 60% | 18.42 | 173 / 286 |
| uterus | 2% | 41.68 | 3 / 170 | 55% | 28.37 | 254 / 459 |
| skin | 46% | 577.77 | 833 / 1809 | 9% | 1.64 | 43 / 472 |
| lung | 3% | 21.65 | 16 / 578 | 49% | 18.55 | 566 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 42% | 13.45 | 212 / 504 |
| breast | 4% | 35.68 | 19 / 459 | 28% | 4.65 | 318 / 1118 |
| ovary | 13% | 124.21 | 24 / 180 | 16% | 1.47 | 67 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 25% | 2.33 | 45 / 178 |
| prostate | 8% | 63.45 | 19 / 245 | 10% | 0.83 | 50 / 502 |
| kidney | 0% | 0 | 0 / 89 | 6% | 0.56 | 52 / 901 |
| thymus | 0% | 0 | 0 / 653 | 4% | 0.37 | 23 / 605 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.19 | 1 / 29 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.24 | 1 / 80 |
| adipose | 0% | 4.04 | 6 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 1.09 | 2 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046676 | Biological process | negative regulation of insulin secretion |
| GO_0045921 | Biological process | positive regulation of exocytosis |
| GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | VSNL1 |
| Protein name | Uncharacterized protein VSNL1 Visinin-like protein 1 (VILIP) (VLP-1) (Hippocalcin-like protein 3) (HLP3) Visinin-like protein 1 |
| Synonyms | VISL1 |
| Description | FUNCTION: Regulates (in vitro) the inhibition of rhodopsin phosphorylation in a calcium-dependent manner. . FUNCTION: Regulates (in vitro) the inhibition of rhodopsin phosphorylation in a calcium-dependent manner. . FUNCTION: Regulates (in vitro) the inhibition of rhodopsin phosphorylation in a calcium-dependent manner. . FUNCTION: Regulates (in vitro) the inhibition of rhodopsin phosphorylation in a calcium-dependent manner. . |
| Accessions | ENST00000295156.9 ENST00000406397.1 E7ER47 ENST00000451533.5 P62760 Q53RT2 ENST00000404666.6 ENST00000457525.5 E9PE24 Q4ZFX3 |
